simplyStocks
Veeva Systems
VEEV · NYSEHealthcare IT / Life-sciences software
The economic chain
Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
$30B
P/E ratio
29×
Div yield
0%
Revenue (FY26)
$3.2B
Rev. growth
+16%
Net income
$909M
Op. margin
29%
Free cash flow
$1.4B
In plain English
Veeva is the software backbone of the drug industry: it builds the cloud applications that pharma and biotech run their businesses on — the systems that manage clinical trials, regulatory filings, quality and manufacturing records (Development & Quality Cloud), and the CRM and data tools sales reps use to reach doctors (Commercial Cloud). It is a vertical SaaS company that sells almost exclusively to life sciences, and is in the middle of moving its flagship CRM off Salesforce onto its own Vault platform.
In simple terms
What Veeva Systems really sells
Veeva is the software backbone of the drug industry: it builds the cloud applications that pharma and biotech run their businesses on — the systems that manage clinical trials, regulatory filings, quality and manufacturing records (Development & Quality Cloud), and the CRM and data tools sales reps use to reach doctors (Commercial Cloud). It is a vertical SaaS company that sells almost exclusively to life sciences, and is in the middle of moving its flagship CRM off Salesforce onto its own Vault platform.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.
Risk read
SteadierMore speculative
Why this rating?